Cubist Systematic Strategies’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-138
| Closed | -$3.43K | – | 1768 |
|
|
2024
Q4 | $3.43K | Buy |
+138
| New | +$3.43K | ﹤0.01% | 1415 |
|
|
2024
Q2 | – | Sell |
-498
| Closed | -$149K | – | 1902 |
|
|
2024
Q1 | $149K | Buy |
+498
| New | +$149K | ﹤0.01% | 1747 |
|
|
2023
Q2 | – | Sell |
-449
| Closed | -$56.6K | – | 2555 |
|
|
2023
Q1 | $56.6K | Sell |
449
-34
| -7% | -$4.29K | ﹤0.01% | 2510 |
|
|
2022
Q4 | $146K | Buy |
+483
| New | +$146K | ﹤0.01% | 2757 |
|
|
2021
Q2 | – | Sell |
-269
| Closed | -$81K | – | 2973 |
|
|
2021
Q1 | $81K | Buy |
269
+103
| +62% | +$31K | ﹤0.01% | 2680 |
|
|
2020
Q4 | $62K | Buy |
+166
| New | +$62K | ﹤0.01% | 2449 |
|
|
2018
Q4 | – | Sell |
-51
| Closed | -$74K | – | 2135 |
|
|
2018
Q3 | $74K | Buy |
+51
| New | +$74K | ﹤0.01% | 1634 |
|
|
2018
Q2 | – | Sell |
-33
| Closed | -$54K | – | 1876 |
|
|
2018
Q1 | $54K | Buy |
+33
| New | +$54K | ﹤0.01% | 1693 |
|